Phosphodiesterases (PDEs) also designated cyclic nucleotide phosphodiesterases, are important for the downregulation of the intracellular level of the second messenger cyclic adenosine monophosphate (cAMP) by hydrolyzing cAMP to 5'AMP. Phosphodiesterase 9A (PDE9A) is a 593 amino acid protein that plays a role in signal transduction via regulation of the intracellular concentration of cyclic nucleotides and has a high affinity for cGMP. There are 15 known isoforms of PDE9A. It is expressed in various tissues including testis, brain, small intestine, skeletal muscle, heart, lung, thymus, spleen, placenta, kidney, liver, pancreas, ovary and prostate. Highest levels of PDE9A expression occur in brain, kidney, spleen, colon, heart and colon, while there is no detection of PDE9A in blood. PDE9A is composed of an N-terminal regulatory domain and a C-terminal catalytic domain containing two possible divalent metal sites. It may be implicated in affective bipolar disorder.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps PDE9A (G-4) | sc-166375 | 200 µg/ml | $316.00 | |||
PDE9A (G-4): m-IgG Fc BP-HRP Kit | sc-540090 | 200 µg Ab; 10 µg BP | $354.00 | |||
PDE9A (G-4): m-IgG1 BP-HRP Kit | sc-541899 | 200 µg Ab; 20 µg BP | $354.00 | |||
PDE9A (G-4) peptide neutralisant | sc-166375 P | 100 µg/0.5 ml | $68.00 |